NYSE American - Nasdaq Real Time Price USD
Matinas BioPharma Holdings, Inc. (MTNB)
0.8801
+0.0001
+(0.01%)
At close: 3:59:54 PM EDT
0.8601
-0.02
(-2.27%)
After hours: 6:15:31 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -0.85 | -4.08 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|
| EPS Est. | -1 | -1.05 | -0.78 |
| EPS Actual | -0.02 | -0.85 | -0.81 |
| Difference | 0.98 | 0.2 | -0.03 |
| Surprise % | 98.00% | 19.43% | -3.28% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MTNB | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.45% | 7.54% | 14.08% |
Upgrades & Downgrades
| Downgrade | Maxim Group: Buy to Hold | 10/31/2024 |
| Reiterates | HC Wainwright & Co.: Buy | 1/31/2023 |
| Maintains | Aegis Capital: Buy | 8/13/2020 |
| Initiated | Piper Sandler: Overweight | 1/27/2020 |
| Initiated | SunTrust Robinson Humphrey: Buy | 1/24/2020 |
| Initiated | HC Wainwright & Co.: Buy | 6/26/2019 |
Related Tickers
ENTO Entero Therapeutics, Inc.
0.5890
+10.05%
ZVSA ZyVersa Therapeutics, Inc.
0.7000
+9.41%
PCSA Processa Pharmaceuticals, Inc.
0.3435
+5.79%
BCLI Brainstorm Cell Therapeutics Inc.
1.2500
+0.81%
BDRX Biodexa Pharmaceuticals Plc
1.1400
-0.87%
ENVB Enveric Biosciences, Inc.
1.2800
-1.54%
AEON AEON Biopharma, Inc.
0.9400
+7.71%
KAPA Kairos Pharma, Ltd.
0.5440
-3.99%
RENB Renovaro Inc.
0.3805
+5.61%
EQ Equillium, Inc.
0.3506
-7.74%